Gene · 28402
Papers3,091
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 3,091
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Long-term benefit of IGHV mutated patients in a real-life multicenter cohort of FCR-treated chronic lymphocytic leukemia. | Hematol Oncol | 2023 | 36190298 | PubTator, text mining | PubMed |
| Sex differences in lymphoma incidence and mortality by subtype: A population-based study. | Am J Hematol | 2023 | 36178436 | PubTator, text mining | PubMed |
| Diffuse Large B-cell Lymphoma Involving an Abundant Infiltration of T Follicular Helper Cells. | Intern Med | 2023 | 36130892 | PubTator, text mining | PubMed |
| Expression of BCL11A in chronic lymphocytic leukaemia. | Int J Lab Hematol | 2023 | 36120992 | PubTator, text mining | PubMed |
| Extracellular Vesicle Secretion by Leukemia Cells In Vivo Promotes CLL Progression by Hampering Antitumor T-cell Responses. | Blood Cancer Discov | 2023 | 36108149 | PubTator, text mining | PubMed |
| Detecting measurable residual disease beyond 10-4 by an IGHV leader-based NGS approach improves prognostic stratification in CLL. | Blood | 2023 | 36084320 | PubTator, text mining | PubMed |
| Induction of neutralizing antibodies in CLL patients after SARS-CoV-2 mRNA vaccination: a monocentric experience. | Clin Exp Med | 2023 | 36074205 | PubTator, text mining | PubMed |
| Ibrutinib in patients over 80 years old with CLL: a multicenter Italian cohort. | Blood Adv | 2023 | 35930765 | PubTator, text mining | PubMed |
| PI3K inhibitors in chronic lymphocytic leukemia: where do we go from here? | Haematologica | 2023 | 35899388 | PubTator, text mining | PubMed |
| The immune microenvironment shapes transcriptional and genetic heterogeneity in chronic lymphocytic leukemia. | Blood Adv | 2023 | 35358998 | PubTator, text mining | PubMed |
| Prognostic value of serum progranulin in de novo adult acute myeloid leukemia patients. | Hematol Transfus Cell Ther | 2023 | 34294600 | PubTator, text mining | PubMed |
| Enhanced Costimulatory Signaling Improves CAR T-cell Effector Responses in CLL. | Cancer Res Commun | 2022 | 36922932 | PubTator, text mining | PubMed |
| Editorial: Biology and treatment of high-risk CLL. | Front Oncol | 2022 | 36891501 | PubTator, text mining | PubMed |
| Redirecting T-cell Activity with Anti-BCMA/Anti-CD3 Bispecific Antibodies in Chronic Lymphocytic Leukemia and Other B-cell Lymphomas. | Cancer Res Commun | 2022 | 36875718 | PubTator, text mining | PubMed |
| [Clonality relatedness and molecular characteristics of Richter transformation]. | Zhonghua Xue Ye Xue Za Zhi | 2022 | 36709198 | PubTator, text mining | PubMed |
| [Interpretation of the guidelines for diagnosis and treatment of mantle cell lymphoma in China (2022)]. | Zhonghua Xue Ye Xue Za Zhi | 2022 | 36709180 | PubTator, text mining | PubMed |
| A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Deficiency. | Curr Oncol | 2022 | 36661671 | PubTator, text mining | PubMed |
| Coronavirus-Specific Antibody and T Cell Responses Developed after Sputnik V Vaccination in Patients with Chronic Lymphocytic Leukemia. | Int J Mol Sci | 2022 | 36613860 | PubTator, text mining | PubMed |
| A survival prediction model and nomogram based on immune-related gene expression in chronic lymphocytic leukemia cells. | Front Med (Lausanne) | 2022 | 36600891 | PubTator, text mining | PubMed |
| Ancestral reconstruction reveals catalytic inactivation of activation-induced cytidine deaminase concomitant with cold water adaption in the Gadiformes bony fish. | BMC Biol | 2022 | 36575514 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/28402/papers?page=24